Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk
H. Amarens Geuzinge(Erasmus MC), Emiel J. Rutgers(Oncode Institute), Jelle Wesseling(Leiden University Medical Center), Ernest J. T. Luiten(Amphia Ziekenhuis), Marc B. I. Lobbes(Maastricht University Medical Centre), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Margreet G.E.M. Ausems(McGill University Health Centre), Eveline A.M. Heijnsdijk(Erasmus MC), Claudette E. Loo(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Harmien M. Zonderland(Leiden University Medical Center), Maartje J. Hooning(Erasmus MC Cancer Institute), Ritse M. Mann(Radboud University Nijmegen), Harry J. de Koning(Erasmus MC), Jan C. Oosterwijk(University Medical Center Groningen), Madeleine M.A. Tilanus‐Linthorst(Erasmus University Rotterdam), Diderick B. W. de Roy van Zuidewijn(Medisch Centrum Leeuwarden), Martijne van ’t Riet(Reinier de Graaf Hospital), Sepideh Saadatmand(Erasmus MC), Inge-Marie Obdeijn, Cees Verhoef(Erasmus MC)
Cited by 53
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k